Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit

by | October 30, 2025 4:21 pm | US Markets

Merck said its narrowed profit guidance reflects several new items, including “lower estimated costs related to the impact of tariffs.”